Jianerkang Medical Co.,Ltd. (SHA:603205)
22.53
+0.74 (3.40%)
At close: Jun 12, 2026
Jianerkang Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 398.61 | 764.91 | 721.81 | 226.24 | 178.25 | 97.8 |
Cash & Short-Term Investments | 772.39 | 764.91 | 721.81 | 226.24 | 178.25 | 97.8 |
Cash Growth | 3.28% | 5.97% | 219.05% | 26.92% | 82.27% | 3.28% |
Accounts Receivable | 213.2 | 255.99 | 212.32 | 235.5 | 189.16 | 138.75 |
Other Receivables | 8.07 | 11.99 | 14.4 | 9.04 | 4.43 | 6.96 |
Receivables | 221.27 | 267.98 | 226.72 | 244.54 | 193.59 | 145.71 |
Inventory | 181.7 | 167.02 | 176.3 | 158.41 | 170.44 | 158.62 |
Prepaid Expenses | - | 0.25 | - | 0.52 | 9.01 | 0.09 |
Other Current Assets | 21.36 | 9.44 | 10.32 | 11.07 | 20.71 | 8.39 |
Total Current Assets | 1,197 | 1,210 | 1,135 | 640.78 | 572.01 | 410.6 |
Property, Plant & Equipment | 381.99 | 380.05 | 365.42 | 383.67 | 356.1 | 326.67 |
Other Intangible Assets | 56.94 | 57.32 | 58.41 | 59.92 | 61.39 | 63.19 |
Long-Term Deferred Tax Assets | 25.61 | 25.93 | 23.02 | 23.12 | 25.96 | 24.37 |
Long-Term Deferred Charges | 33.76 | 33.04 | 6.6 | 3.02 | 2.09 | 2.07 |
Other Long-Term Assets | 5.2 | 4.67 | 1.97 | 3.06 | 10.93 | 13.52 |
Total Assets | 1,700 | 1,711 | 1,591 | 1,114 | 1,028 | 840.43 |
Accounts Payable | 97.7 | 96.38 | 87.33 | 103.14 | 95.25 | 73.14 |
Accrued Expenses | 15.54 | 37.12 | 27.7 | 34.07 | 42.3 | 31.45 |
Short-Term Debt | - | - | - | - | 30.04 | 50.05 |
Current Portion of Leases | 3.95 | 5.23 | - | - | - | - |
Current Income Taxes Payable | 5.73 | 5.37 | 3.44 | 7.78 | 4.77 | 1.43 |
Current Unearned Revenue | 5.45 | 6.19 | 6.48 | 4.32 | 8.85 | 4.59 |
Other Current Liabilities | 2.26 | 16.9 | 9.79 | 16.47 | 21.98 | 14.76 |
Total Current Liabilities | 130.62 | 167.18 | 134.74 | 165.79 | 203.19 | 175.42 |
Long-Term Leases | 15.11 | 16.54 | - | - | - | - |
Long-Term Unearned Revenue | 30.19 | 31 | 34.64 | 38.24 | 41.8 | 47.76 |
Long-Term Deferred Tax Liabilities | 1.61 | 1.45 | 1.06 | 0.19 | 0.19 | 0.2 |
Total Liabilities | 177.54 | 216.16 | 170.43 | 204.22 | 245.18 | 223.39 |
Common Stock | 156 | 156 | 120 | 90 | 90 | 90 |
Additional Paid-In Capital | 681.79 | 680.37 | 710.69 | 350.13 | 347.62 | 338.7 |
Retained Earnings | 686.24 | 658.76 | 589.44 | 469.22 | 345.68 | 188.34 |
Comprehensive Income & Other | -1.34 | -0.67 | -0 | - | - | - |
Shareholders' Equity | 1,523 | 1,494 | 1,420 | 909.35 | 783.29 | 617.04 |
Total Liabilities & Equity | 1,700 | 1,711 | 1,591 | 1,114 | 1,028 | 840.43 |
Total Debt | 19.06 | 21.76 | - | - | 30.04 | 50.05 |
Net Cash (Debt) | 753.33 | 743.15 | 721.81 | 226.24 | 148.21 | 47.75 |
Net Cash Growth | 0.73% | 2.96% | 219.05% | 52.65% | 210.40% | 89.99% |
Net Cash Per Share | 4.86 | 4.73 | 5.82 | 1.93 | 1.27 | 0.41 |
Filing Date Shares Outstanding | 156 | 156 | 156 | 117 | 117 | 117 |
Total Common Shares Outstanding | 156 | 156 | 156 | 117 | 117 | 117 |
Working Capital | 1,066 | 1,042 | 1,000 | 474.99 | 368.82 | 235.18 |
Book Value Per Share | 9.76 | 9.58 | 9.10 | 7.77 | 6.70 | 5.27 |
Tangible Book Value | 1,466 | 1,437 | 1,362 | 849.43 | 721.91 | 553.85 |
Tangible Book Value Per Share | 9.40 | 9.21 | 8.73 | 7.26 | 6.17 | 4.73 |
Buildings | - | 295.88 | 295.48 | 294.63 | 241.34 | 233.68 |
Machinery | - | 354.99 | 346.13 | 321.4 | 303.54 | 259.27 |
Construction In Progress | - | 26.99 | 4.97 | 11.9 | 17.36 | 7.33 |